201 related articles for article (PubMed ID: 9306349)
21. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Ponticelli C; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda G; Corbetta G
J Am Soc Nephrol; 1997 Apr; 8(4):638-46. PubMed ID: 10495794
[TBL] [Abstract][Full Text] [Related]
22. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET
Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200
[TBL] [Abstract][Full Text] [Related]
23. Do cyclosporin profiles provide useful information in the management of renal transplant recipients?
Bowles MJ; Waters JB; Lechler RI; Williams G
Nephrol Dial Transplant; 1996 Aug; 11(8):1597-602. PubMed ID: 8856218
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
25. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
Cantarovich D; Karam G; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Le Normand L; Soulillou JP
Kidney Int; 1998 Oct; 54(4):1351-6. PubMed ID: 9767555
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
Castelao AM; Griño JM; Sabate I; Seron D; Andres E; Gilvernet S; Bover J; Gonzalez C; Alsina J
Transpl Int; 1992; 5 Suppl 1():S58-9. PubMed ID: 14621732
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation.
Montagnino G; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Castagneto M; Salvadori M; Cossu M; Pisani F; Carmellini M; Mastrangelo F; Ferrara R; Ponticelli C
J Am Soc Nephrol; 2001 Oct; 12(10):2163-2169. PubMed ID: 11562416
[TBL] [Abstract][Full Text] [Related]
29. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
31. mTOR inhibitor monotherapy. A good treatment choice in renal transplantation?
Franco-Esteve A; Tordera D; de la Sen ML; Jiménez L; Mas P; Muñoz C; Olivares J
Nefrologia; 2012; 32(5):631-8. PubMed ID: 23013949
[TBL] [Abstract][Full Text] [Related]
32. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
[TBL] [Abstract][Full Text] [Related]
34. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
Kasiske BL; Johnson HJ; Goerdt PJ; Heim-Duthoy KL; Rao VK; Dahl DC; Ney AL; Andersen RC; Jacobs DM; Odland MD
Am J Kidney Dis; 1997 Nov; 30(5):639-45. PubMed ID: 9370178
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of kidney transplantation between HLA-identical siblings.
Moon JI; Kim YS; Chung SY; Kim MS; Kim SI; Park K
Surg Today; 2001; 31(2):123-8. PubMed ID: 11291705
[TBL] [Abstract][Full Text] [Related]
37. The utility of cyclosporine weaning in renal transplantation.
Loertscher R; Blier L; Steinmetz O; Nohr C
Ann Surg; 1992 Apr; 215(4):368-76. PubMed ID: 1558418
[TBL] [Abstract][Full Text] [Related]
38. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
Kandus A; Grego K; Bren AF
Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
[TBL] [Abstract][Full Text] [Related]
39. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
